Arnaud Lallouette, Executive Vice President Global Medical and Patient Affairs at Servier, shared on LinkedIn:
“Philadelphia is a city where history is still very much present, reminding that progress is built on what came before us and on our determination to shape what comes next.
I felt a similar spirit at the 31st Annual Society for Neuro-Oncology Congress (SNO): learning from scientific experience, challenging our knowledge today, and looking with hope toward the innovations that could change the future of brain tumor care.
It was a privilege to attend, speak, listen, and exchange with the medical and scientific community on some of the important questions that could shape the future of brain tumor management.

For us at Servier, this means more than sharing where our science stands today. It means listening carefully to clinicians, researchers, and patients so that their perspectives continue to shape the evidence we generate and, just as importantly, the questions we choose to pursue.
Our team may not have every answer today. But progress starts with asking the right questions. And by listening, challenging our thinking, and working together with the scientific and medical community and with patients, we can help create the evidence and innovation needed for a better future.
Delighted to represent Servier with my Excom colleagues Philippe Gonnard, Claude Bertrand, and David K. Lee, together with the Global Medical and Patient Affairs team so active and committed, and Servier colleagues present from all over the world.”
You may also be interested in: